Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H35N5.2Cl.Mn |
| Molecular Weight | 483.38 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[Mn++].C1CC[C@H]2NCC3=CC=CC(CN[C@@H]4CCCC[C@H]4NCCN[C@@H]2C1)=N3
InChI
InChIKey=WXEMWBBXVXHEPU-XNPJUPKFSA-L
InChI=1S/C21H35N5.2ClH.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;;;/h5-7,18-25H,1-4,8-15H2;2*1H;/q;;;+2/p-2/t18-,19-,20-,21-;;;/m1.../s1
| Molecular Formula | C21H35N5 |
| Molecular Weight | 357.5361 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Mn |
| Molecular Weight | 54.938045 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Imisopasem Manganese is a manganese-based non-peptidyl mimetic of the human mitochondrial manganese superoxide dismutase (MnSOD), with potential antioxidant and radioprotective activities. Metaphore Pharmaceuticals Inc. is developing Imisopasem Manganese for the potential treatment of pain, dermatological disease and inflammation. Upon administration, imisopasem manganese mimics the activity of MnSOD and scavenges reactive oxygen species (ROS), such as superoxide anion, which prevents oxygen free radical damage to macromolecules such as DNA. This reduces ROS-mediated lipid peroxidation, prevents apoptosis and protects against oxygen free radical-induced toxicity in normal tissues.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. | 2003-07 |
|
| A role for superoxide in gentamicin-mediated nephropathy in rats. | 2002-08-16 |
|
| Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. | 2001-02 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00101621
single doses of 0.0625, 0.125, and 0.25 mg/kg
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:40:39 GMT 2025
by
admin
on
Wed Apr 02 09:40:39 GMT 2025
|
| Record UNII |
2Q6R3259KS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C275
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB04976
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
C111684
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
C121876
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
8634
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
SUB190201
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
2Q6R3259KS
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
6918487
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
100000175707
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
m6235
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
218791-21-0
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
DTXSID20944477
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
QQ-97
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY | |||
|
CHEMBL3544979
Created by
admin on Wed Apr 02 09:40:39 GMT 2025 , Edited by admin on Wed Apr 02 09:40:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
TARGET->MIMETIC | |||
|
PARENT -> SALT/SOLVATE |